Chris Prentiss

Chief Financial Officer at MannKind

Speaker

Chris Prentiss guides the financial strategy for the company, drawing on nearly 20 years of biotech industry experience with both private and public companies. A successful executive in financial and accounting, he is focused on delivering on corporate goals, building shareholder value, and helping drive MannKind’s mission.

Chris joined MannKind in 2024 after serving as Chief Financial Officer of ADARx Pharmaceuticals, Inc., where he helped raise nearly $250 million in funding. Prior to that he spent six years with Adamas Pharmaceuticals where he held a series of senior finance positions of increasing responsibility that culminated with CFO. Chris was first introduced to the biopharmaceutical arena in 2005 when he first joined MannKind; he initially spent six-plus years with the company, including as its Corporate Controller. Chris started his career at KPMG, where he spent almost eight years in the audit practice.